Restricted accessResearch articleFirst published online 2021-11
Aqueous Azadirachta indica (Neem) Extract Attenuates Insulin Resistance to Improve Glycemic Control and Endothelial Function in Subjects with Metabolic Syndrome
Neem (Azadirachta indica) exhibits multiple therapeutic benefits in preclinical studies, but clinical studies are lacking. This clinical study investigated the efficacy and safety of an aqueous A. indica leaf and twig extract (NEEM) on metabolic parameters in subjects with metabolic syndrome (MetS). Subjects were randomized to receive (1) placebo or (2) 125 mg, (3) 250 mg, or (4) 500 mg of NEEM twice daily (n = 20/group) for 12 weeks. Fasting blood sugar (FBS) and insulin, postprandial blood sugar (PPBS), insulin resistance (IR), hemoglobin A1c (HbA1c), endothelial function, circulating markers of inflammation and oxidative stress, lipid profiles, and platelet aggregation were measured at weeks 0, 4, 8, and 12. NEEM supplementation dose dependently improved the trajectories for FBS, PPBS, IR, and HbA1c over time, as well as endothelial function and most markers of inflammation and oxidative stress. Therefore, NEEM may be considered a promising therapeutic to attenuate the hyperglycemia and associated cardiometabolic derangements in people with MetS. Clinical trial registration no.: CTRI/2019/03/018034 [registered on: March 12, 2019].
AlbertiKGMM, EckelRH, GrundySM, et al.: Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American Heart Association; World Heart Federation; International. Circulation, 2009; 120:1640–1645.
3.
AlbertiKGMM, ZimmetP, ShawJ: The metabolic syndrome—a new worldwide definition. Lancet, 2005; 366:1059–1062.
4.
FordES: Prevalence of the metabolic syndrome defined by the international diabetes federation among adults in the U.S. Diabetes Care, 2005; 28:2745–2729.
5.
ChoNH, ShawJE, KarurangaS, et al.: IDF diabetes atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract, 2018; 138:271–281.
RivelleseAA, RiccardiG, VaccaroO: Cardiovascular risk in women with diabetes. Nutr Metab Cardiovasc Dis, 2010; 20:474–480.
8.
Guerrero-RomeroF, Rodríguez-MoránM: Hypomagnesemia, oxidative stress, inflammation, and metabolic syndrome. Diabetes Metab Res Rev, 2006; 22:471–476.
9.
DeanfieldJE, HalcoxJP, RabelinkTJ: Endothelial function and dysfunction: Testing and clinical relevance. Circulation, 2007; 115:1285–1295.
10.
EmotoM, NishizawaY, KawagishiT, et al.: Stiffness indexes β of the common carotid and femoral arteries are associated with insulin resistance in niddm. Diabetes Care, 1998; 21:1178–1182.
11.
HenryPD: Inappropriate coronary vasomotion excessive constriction and insufficient dilation. In: Physiology and Pathophysiology of the Heart, 2nd Edition (HenryPD, ed.). Springer, Boston, MA, 1989, pp. 975–991.
NeatonJD, BlackburnH, JacobsD, et al.: Serum cholesterol level and mortality findings for men screened in the multiple risk factor intervention trial. Arch Intern Med, 1992; 152:1490–1500.
14.
PaulR, PrasadM, SahNK: Anticancer biology of Azadirachta indica l (neem): A mini review. Cancer Biol Ther, 2011; 12:467–476.
GautamMK, GangwarM, SinghSK, GoelRK: Effects of Azadirachta indica on vascular endothelial growth factor and cytokines in diabetic deep wound. Planta Med, 2015; 81:713–721.
17.
SatyanarayanaK, SravanthiK, ShakerI, PonnulakshmiR: Molecular approach to identify antidiabetic potential of Azadirachta indica. J Ayurveda Integr Med, 2015; 6:165–174.
18.
KhanIN, HabibMR, RahmanMM, MannanA, SarkerMMI, HawladerS: Thrombolytic potential of Ocimum sanctum L., Curcuma longa L., Azadirachta indica L. and Anacardium occidentale L. J Basic Clin Pharm, 2011; 2:125–127.
19.
BishtS, SisodiaSS: Anti-hyperglycemic and antidyslipidemic potential of Azadirachta indica leaf extract in STZ-induced diabetes mellitus. J Pharm Sci Res, 2010; 2:622–627.
20.
ChattopadhyayR, BandyopadhyayM: Effect of Azadirachta indica leaf extract on serum lipid profile changes in normal and streptozotocin induced diabetic rats. Afr J Biomed Res, 2006; 8:101–104.
21.
ShaileyS, BasirSF: Long term effect of Azadirachta indica on hyperglycemia, associated hyperlipidemia and tissue glycogen content in alloxan induced diabetic rats. J Pharm Res, 2011; 4:810–812.
22.
PingaliU, AliMA, GundaganiS, et al.: Evalutation of the effect of an aqueous extract of Azadirachta indica (neem) leaves and twigs on glycemic control, endothelial dysfunction and systemic inflammation in subjects with type 2 diabetes mellitus—a randomized, double-blind, placebo-controlled clinical study. Diabetes Metab Syndr Obes, 2020; 13:4401–4412.
23.
ChowienczykPJ, KellyRP, MacCallumH, et al.: Photoplethysmographic assessment of pulse wave reflection: Blunted response to endothelium-dependent beta2-adrenergic vasodilation in type II diabetes mellitus. J Am Coll Cardiol, 1999; 37:2007–2014.
24.
NaiduMUR, SridharY, RaniPU, MateenAA: Comparison of two β2 adrenoceptor agonists by different routes of administration to assess human endothelial function. Indian J Pharmacol, 2007; 39:168–169.
25.
Gayoso-DizP, Otero-GonzálezA, Rodriguez-AlvarezMX, et al.: Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: Effect of gender and age: Epirce cross-sectional study. BMC Endocr Disord, 2013; 13:47.
26.
DemircanN, GürelA, ArmutcuF, ÜnalacakM, AktunçE, AtmacaH: The evaluation of serum cystatin C, malondialdehyde, and total antioxidant status in patients with metabolic syndrome. Med Sci Monit, 2008; 14:CR97–CR101.
27.
BarbatoJE, ZuckerbraunBS, OverhausM, RamanKG, TzengE: Nitric oxide modulates vascular inflammation and intimal hyperplasia in insulin resistance and the metabolic syndrome. Am J Physiol Hear Circ Physiol, 2005; 289:H228-H236.
28.
SunYX, HuSJ, ZhangXH, SunJ, ZhuCH, ZhangZJ: Plasma levels of vWF and NO in patients with metabolic syndrome and their relationship with metabolic disorders. Zhejiang Da Xue Xue Bao Yi Xue Ban J Zhejiang Univ Med Sci, 2006; 35:315–318.
29.
EsserN, Legrand-PoelsS, PietteJ, ScheenAJ, PaquotN: Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract, 2014; 105:141–150.
30.
Perez GutierrezRM, De Jesus Martinez OrtizM: Beneficial effect of Azadirachta indica on advanced glycation end-product in streptozotocin-diabetic rat. Pharm Biol, 2014; 1435–1444.
31.
KoulA, BharrhanS, SinghB, RishiP: Potential of Azadirachta indica against Salmonella Typhimurium-induced inflammation in balb/c mice. Inflammopharmacology, 2009; 17:29–36.
32.
LeeJW, RyuHW, ParkSY, et al.: Protective effects of neem (Azadirachta indica a. juss.) leaf extract against cigarette smoke- and lipopolysaccharide-induced pulmonary inflammation. Int J Mol Med, 2017; 40:1932–1940.
33.
MorrisJ, GonzalesCB, De La ChapaJJ, et al.: The highly pure neem leaf extract, scne, inhibits tumorigenesis in oral squamous cell carcinoma via disruption of pro-tumor inflammatory cytokines and cell signaling. Front Oncol, 2019; 9:890.
34.
PatelM, TripathyS, MukhopadhyayK, et al.: A supercritical CO2 extract of neem leaf (A. indica) and its bioactive liminoid, nimbolide, suppresses colon cancer in preclinical models by modulating pro-inflammatory pathways. Mol Carcinog, 2018; 57:1156–1165.
35.
BharitkarYP, BathiniS, OjhaD, et al.: Antibacterial and antiviral evaluation of sulfonoquinovosyldiacylglyceride: A glycolipid isolated from Azadirachta indica leaves. Lett Appl Microbiol, 2014; 58:184–189.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
